Literature DB >> 31630392

Endosomal toll-like receptors play a key role in activation of primary human monocytes by cowpea mosaic virus.

Marwah M Albakri1,2, Frank A Veliz3, Steven N Fiering4, Nicole F Steinmetz5,6,7,8, Scott F Sieg9.   

Abstract

The plant virus, cowpea mosaic virus (CPMV), has demonstrated a remarkable capacity to induce anti-tumour immune responses following direct administration into solid tumours. The molecular pathways that account for these effects and the capacity of CPMV to activate human cells are not well defined. Here, we examine the ability of CPMV particles to activate human monocytes, dendritic cells (DCs) and macrophages. Monocytes in peripheral blood mononuclear cell cultures and purified CD14+ monocytes were readily activated by CPMV in vitro, leading to induction of HLA-DR, CD86, PD-L1, IL-15R and CXCL10 expression. Monocytes released chemokines, CXCL10, MIP-1α and MIP-1β into cell culture supernatants after incubation with CPMV. DC subsets (pDC and mDC) and monocyte-derived macrophages also demonstrated evidence of activation after incubation with CPMV. Inhibitors of spleen tyrosine kinase (SYK), endocytosis or endocytic acidification impaired the capacity of CPMV to activate monocytes. Furthermore, CPMV activation of monocytes was partially blocked by a TLR7/8 antagonist. These data demonstrate that CPMV activates human monocytes in a manner dependent on SYK signalling, endosomal acidification and with an important contribution from TLR7/8 recognition.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  Syk signalling; TLR7/8; cowpea mosaic virus; endosome inhibitor; monocytes

Mesh:

Substances:

Year:  2019        PMID: 31630392      PMCID: PMC6954739          DOI: 10.1111/imm.13135

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  63 in total

1.  Monocyte-derived dendritic cells generated after a short-term culture with IFN-alpha and granulocyte-macrophage colony-stimulating factor stimulate a potent Epstein-Barr virus-specific CD8+ T cell response.

Authors:  Laura Santodonato; Giuseppina D'Agostino; Roberto Nisini; Sabrina Mariotti; Domenica M Monque; Massimo Spada; Laura Lattanzi; Maria Paola Perrone; Mauro Andreotti; Filippo Belardelli; Maria Ferrantini
Journal:  J Immunol       Date:  2003-05-15       Impact factor: 5.422

Review 2.  Contact, Collaboration, and Conflict: Signal Integration of Syk-Coupled C-Type Lectin Receptors.

Authors:  Jenny Ostrop; Roland Lang
Journal:  J Immunol       Date:  2017-02-15       Impact factor: 5.422

3.  Biodistribution, pharmacokinetics, and blood compatibility of native and PEGylated tobacco mosaic virus nano-rods and -spheres in mice.

Authors:  Michael A Bruckman; Lauren N Randolph; Allen VanMeter; Stephen Hern; Andrew J Shoffstall; Rebecca E Taurog; Nicole F Steinmetz
Journal:  Virology       Date:  2013-12-05       Impact factor: 3.616

4.  Structural Analysis Reveals that Toll-like Receptor 7 Is a Dual Receptor for Guanosine and Single-Stranded RNA.

Authors:  Zhikuan Zhang; Umeharu Ohto; Takuma Shibata; Elena Krayukhina; Masato Taoka; Yoshio Yamauchi; Hiromi Tanji; Toshiaki Isobe; Susumu Uchiyama; Kensuke Miyake; Toshiyuki Shimizu
Journal:  Immunity       Date:  2016-10-11       Impact factor: 31.745

Review 5.  Classification, mechanisms of action, and therapeutic applications of inhibitory oligonucleotides for Toll-like receptors (TLR) 7 and 9.

Authors:  Petar S Lenert
Journal:  Mediators Inflamm       Date:  2010-05-18       Impact factor: 4.711

6.  TIE-2 and VEGFR kinase activities drive immunosuppressive function of TIE-2-expressing monocytes in human breast tumors.

Authors:  Mark Ibberson; Sylvian Bron; Nicolas Guex; Eveline Faes-van't Hull; Assia Ifticene-Treboux; Luc Henry; Hans-Anton Lehr; Jean-François Delaloye; George Coukos; Ioannis Xenarios; Marie-Agnès Doucey
Journal:  Clin Cancer Res       Date:  2013-05-06       Impact factor: 12.531

7.  Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors.

Authors:  Michele De Palma; Mary Anna Venneri; Rossella Galli; Lucia Sergi Sergi; Letterio S Politi; Maurilio Sampaolesi; Luigi Naldini
Journal:  Cancer Cell       Date:  2005-09       Impact factor: 31.743

Review 8.  Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases.

Authors:  Md Abdul Alim Al-Bari
Journal:  Pharmacol Res Perspect       Date:  2017-01-23

9.  Syk kinase is required for collaborative cytokine production induced through Dectin-1 and Toll-like receptors.

Authors:  Kevin M Dennehy; Gerben Ferwerda; Inês Faro-Trindade; Elwira Pyz; Janet A Willment; Philip R Taylor; Ann Kerrigan; S Vicky Tsoni; Siamon Gordon; Friederike Meyer-Wentrup; Gosse J Adema; Bart-Jan Kullberg; Edina Schweighoffer; Victor Tybulewicz; Hector M Mora-Montes; Neil A R Gow; David L Williams; Mihai G Netea; Gordon D Brown
Journal:  Eur J Immunol       Date:  2008-02       Impact factor: 5.532

10.  Dual Role of the Tyrosine Kinase Syk in Regulation of Toll-Like Receptor Signaling in Plasmacytoid Dendritic Cells.

Authors:  Besma Aouar; Denisa Kovarova; Sebastien Letard; Albert Font-Haro; Jonathan Florentin; Jan Weber; David Durantel; Laurence Chaperot; Joel Plumas; Katerina Trejbalova; Jiri Hejnar; Jacques A Nunès; Daniel Olive; Patrice Dubreuil; Ivan Hirsch; Ruzena Stranska
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

View more
  9 in total

1.  Emerging Potential of Plant Virus Nanoparticles (PVNPs) in Anticancer Immunotherapies.

Authors:  Mehdi Shahgolzari; Steven Fiering
Journal:  J Cancer Immunol (Wilmington)       Date:  2022

Review 2.  Plant Viruses and Bacteriophage-Based Reagents for Diagnosis and Therapy.

Authors:  Sourabh Shukla; He Hu; Hui Cai; Soo-Khim Chan; Christine E Boone; Veronique Beiss; Paul L Chariou; Nicole F Steinmetz
Journal:  Annu Rev Virol       Date:  2020-09-29       Impact factor: 10.431

Review 3.  The pharmacology of plant virus nanoparticles.

Authors:  Christian Isalomboto Nkanga; Nicole F Steinmetz
Journal:  Virology       Date:  2021-01-28       Impact factor: 3.616

4.  Remission-Stage Ovarian Cancer Cell Vaccine with Cowpea Mosaic Virus Adjuvant Prevents Tumor Growth.

Authors:  Courtney T Stump; Gregory Ho; Chenkai Mao; Frank A Veliz; Veronique Beiss; Jennifer Fields; Nicole F Steinmetz; Steven Fiering
Journal:  Cancers (Basel)       Date:  2021-02-05       Impact factor: 6.639

Review 5.  Plant Virus Nanoparticles for Anti-cancer Therapy.

Authors:  Srividhya Venkataraman; Paul Apka; Erum Shoeb; Uzma Badar; Kathleen Hefferon
Journal:  Front Bioeng Biotechnol       Date:  2021-12-15

Review 6.  Self-adjuvanting cancer nanovaccines.

Authors:  Zhiyun Liao; Jing Huang; Pui-Chi Lo; Jonathan F Lovell; Honglin Jin; Kunyu Yang
Journal:  J Nanobiotechnology       Date:  2022-07-26       Impact factor: 9.429

7.  Cowpea mosaic virus stimulates antitumor immunity through recognition by multiple MYD88-dependent toll-like receptors.

Authors:  Chenkai Mao; Veronique Beiss; Jennifer Fields; Nicole F Steinmetz; Steven Fiering
Journal:  Biomaterials       Date:  2021-05-25       Impact factor: 12.479

8.  The unique potency of Cowpea mosaic virus (CPMV) in situ cancer vaccine.

Authors:  Sourabh Shukla; Chao Wang; Veronique Beiss; Hui Cai; Torus Washington; Abner A Murray; Xingjian Gong; Zhongchao Zhao; Hema Masarapu; Adam Zlotnick; Steven Fiering; Nicole F Steinmetz
Journal:  Biomater Sci       Date:  2020-09-30       Impact factor: 7.590

Review 9.  Application of Plant Viruses in Biotechnology, Medicine, and Human Health.

Authors:  Srividhya Venkataraman; Kathleen Hefferon
Journal:  Viruses       Date:  2021-08-26       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.